Skip to main content
. 2024 Apr 17;12(2):71. doi: 10.3390/pharmacy12020071

Table 1.

Frequency of pre-admission time-critical medicine groups and their overall median times from ED presentation to the first dose administration.

Variables Before Accounting for a Potential Clustering Effect After Accounting for a Potential Clustering Effect
PPMC
(n = 107 TCMs)
Early BPMH
(n = 107 TCMs)
Usual Care
(n = 107 TCMs)
p-Value PPMC
(n = 77 TCMs)
Early BPMH
(n = 76 TCMs)
Usual Care
(n = 91 TCMs)
p-Value
Group, n (%)
Anti-coagulants 24 (22%) 23 (21%) 24 (22%) 0.98 * 16 (21%) 21 (28%) 22 (24%) 0.61 *
Anti-convulsants 9 (8.4%) 9 (8.4%) 8 (7.5%) 0.96 * 6 (7.8%) 7 (9.2%) 6 (6.6%) 0.82 *
Anti-Parkinson’s medications 9 (8.4%) 9 (8.4%) 10 (9.3%) 0.96 * 7 (9.1%) 7 (9.2%) 8 (8.8%) 0.99 *
Clozapine 1 (0.9%) 1 (0.9%) 1 (0.9%) >0.99 † 1 (1.3%) 1 (1.3%) 1 (1.1%) >0.99 †
Corticosteroids and hormones 14 (13%) 19 (18%) 16 (15%) 0.63 * 9 (12%) 13 (17%) 14 (15%) 0.63 *
Cytotoxic drugs 0 (0%) 1 (0.9%) 1 (0.9%) >0.99 † - - - -
Immunosuppressants 0 (0%) 1 (0.9%) 0 (0%) >0.99 † - - - -
Insulin 17 (16%) 15 (14%) 16 (15%) 0.93 * 15 (19%) 11 (14%) 13 (14%) 0.60 *
Oral hypoglycaemic agents 33 (31%) 29 (27%) 31 (29%) 0.83 * 23 (30%) 16 (21%) 27 (30%) 0.37 *
Median time, hours (IQR) 8.8 (6.3, 16.3) 17.5 (7.8, 22.9) 15.1 (8.2, 21.1) <0.001 ‡,§ 9.0 (6.3, 16.1) 16.7 (7.1, 22.2) 14.2 (7.3, 21.2) 0.007 ‡,¶

Abbreviations: BPMH, best-possible medication history; ED, emergency department; IQR; interquartile range; n, number; PPMC, partnered pharmacist medication charting; TCMs, time-critical medicines. * Pearson’s chi-square test. † Fisher’s exact test, ‡ KruskalWallis rank sum test. § Dunn’s post-hoc test: <0.001, PPMC vs. early BPMH; 0.002, PPMC vs. usual care; 0.22, early BPMH vs. usual care. ¶ Dunn’s post-hoc test: 0.008, PPMC vs. early BPMH; 0.019, PPMC vs. usual care; 0.53, early BPMH vs. usual care.